基于机器学习的第四代EGFR抑制剂的虚拟查和识别
Hao Chang1, Zeyu Zhang2, Jiaxin Tian1
1State Key Laboratory of Chemical Resource Engineering, Beijing University of Chemical Technology, Beijing 100029, P. R. China.
ACS omega
|January 22, 2024
概括
研究人员利用机器学习发现了新型第四代表皮生长因子受体氨酸激酶抑制剂 (EGFR-TKI). 这些新的抑制剂对包括C797S.在内的高级非小细胞肺癌 (NSCLC) 突变具有强烈活性.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 计算化学计算化学
背景情况:
- 先进的非小细胞肺癌 (NSCLC) 治疗面临的挑战是EGFR C797S突变的出现,使现有的抑制剂无效.
- 对新的治疗策略的需求对于克服EGFR突变NSCLC的耐药性至关重要.
研究的目的:
- 使用机器学习技术识别创新的第四代EGFR氨酸激酶抑制剂 (EGFR-TKI).
- 开发一个预测模型,以发现新的EGFR-TKI候选对抗抗性突变.
主要方法:
- 结合全方位效应模型和拉索模型的融合框架被用于从高维,稀疏的数据中选择关键分子描述器.
- 开发了机器学习模型,以预测潜在的EGFR-TKI的有效性.
- 进行虚拟选,以识别有前途的打击化合物.
主要成果:
- 新型小分子抑制剂的设计和合成基于结构描述符.
- 合成的抑制剂对双重和三重突变的EGFR激酶 (L858R/T790M/C797S和Del19/T790M/C797S) 显示出强烈的活性.
- 机器学习驱动的虚拟查成功识别出了四种具有潜在治疗价值的命中化合物.
结论:
- 机器学习方法可以有效地加速下一代EGFR-TKI的发现.
- 已识别的热门化合物需要进一步研究它们在治疗耐药NSCLC中的治疗潜力.
- 这项研究为开发针对C797S.等具有挑战性的突变的新型EGFR-TKI提供了框架.
相关概念视频
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...